Prophylactic Indomethacin for Patent Ductus Arteriosus

Avron Y. Sweet, Lynn Mahony, Violetta Carnero, Claire Brett, Michael A. Heymann, Ronald I. Clyman

Research output: Contribution to journalLetter

Abstract

To the Editor: In a recent article by Mahony et al. (March 4 issue),* very early treatment with indomethacin was shown to prevent the development of a hemodynamically important shunt through the ductus arteriosus among newborn infants weighing less than 1000 g at birth. One of the important benefits to the indomethacin-treated infants but not to those receiving a placebo was a statistically significant shorter time needed to regain birth weight. Three of the 12 infants who received placebo had necrotizing enterocolitis, but none of the 10 infants given indomethacin had this problem. Although this difference was not found to.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume307
Issue number10
DOIs
StatePublished - Sep 2 1982

Fingerprint

Patent Ductus Arteriosus
Indomethacin
Placebos
Ductus Arteriosus
Necrotizing Enterocolitis
Birth Weight
Parturition
Newborn Infant
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prophylactic Indomethacin for Patent Ductus Arteriosus. / Sweet, Avron Y.; Mahony, Lynn; Carnero, Violetta; Brett, Claire; Heymann, Michael A.; Clyman, Ronald I.

In: New England Journal of Medicine, Vol. 307, No. 10, 02.09.1982.

Research output: Contribution to journalLetter

Sweet, Avron Y. ; Mahony, Lynn ; Carnero, Violetta ; Brett, Claire ; Heymann, Michael A. ; Clyman, Ronald I. / Prophylactic Indomethacin for Patent Ductus Arteriosus. In: New England Journal of Medicine. 1982 ; Vol. 307, No. 10.
@article{e903c3d5f5e74269b858a9caea10a724,
title = "Prophylactic Indomethacin for Patent Ductus Arteriosus",
abstract = "To the Editor: In a recent article by Mahony et al. (March 4 issue),* very early treatment with indomethacin was shown to prevent the development of a hemodynamically important shunt through the ductus arteriosus among newborn infants weighing less than 1000 g at birth. One of the important benefits to the indomethacin-treated infants but not to those receiving a placebo was a statistically significant shorter time needed to regain birth weight. Three of the 12 infants who received placebo had necrotizing enterocolitis, but none of the 10 infants given indomethacin had this problem. Although this difference was not found to.",
author = "Sweet, {Avron Y.} and Lynn Mahony and Violetta Carnero and Claire Brett and Heymann, {Michael A.} and Clyman, {Ronald I.}",
year = "1982",
month = "9",
day = "2",
doi = "10.1056/NEJM198209023071016",
language = "English (US)",
volume = "307",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "10",

}

TY - JOUR

T1 - Prophylactic Indomethacin for Patent Ductus Arteriosus

AU - Sweet, Avron Y.

AU - Mahony, Lynn

AU - Carnero, Violetta

AU - Brett, Claire

AU - Heymann, Michael A.

AU - Clyman, Ronald I.

PY - 1982/9/2

Y1 - 1982/9/2

N2 - To the Editor: In a recent article by Mahony et al. (March 4 issue),* very early treatment with indomethacin was shown to prevent the development of a hemodynamically important shunt through the ductus arteriosus among newborn infants weighing less than 1000 g at birth. One of the important benefits to the indomethacin-treated infants but not to those receiving a placebo was a statistically significant shorter time needed to regain birth weight. Three of the 12 infants who received placebo had necrotizing enterocolitis, but none of the 10 infants given indomethacin had this problem. Although this difference was not found to.

AB - To the Editor: In a recent article by Mahony et al. (March 4 issue),* very early treatment with indomethacin was shown to prevent the development of a hemodynamically important shunt through the ductus arteriosus among newborn infants weighing less than 1000 g at birth. One of the important benefits to the indomethacin-treated infants but not to those receiving a placebo was a statistically significant shorter time needed to regain birth weight. Three of the 12 infants who received placebo had necrotizing enterocolitis, but none of the 10 infants given indomethacin had this problem. Although this difference was not found to.

UR - http://www.scopus.com/inward/record.url?scp=0020473644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020473644&partnerID=8YFLogxK

U2 - 10.1056/NEJM198209023071016

DO - 10.1056/NEJM198209023071016

M3 - Letter

C2 - 7110212

AN - SCOPUS:0020473644

VL - 307

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 10

ER -